Growth Hormone & IGF · Source-reviewed dossier
HGH (GA)
Source-Reviewed Research Dossier
Growth hormone is a protein made by the pituitary gland, a small gland near the brain. It helps control growth, how the body uses protein and fat, and energy balance. Research matters because these are basic body processes, and because approved growth hormone medicines have real risks and strict approved uses. This catalog material is a research protein, not a medicine. Its identity and activity must be checked for each lot, so results from approved drug studies cannot be assumed to apply to it. Its exact handling, purity, and potency depend on lot-specific testing.
Compound overview
Shared values below are consolidated from the current catalog record. They are not independent verification or lot results; request the applicable product specification and ask which lot records are available before ordering.
Product identity
- Product type
- Protein or hormone research material
- Catalog family
- HGH (GA)
- Research category
- Growth Hormone & IGF
- Catalog CAS RN
- 12629-01-5
- Catalog molecular formula
- C990H1528N262O300S7
- Catalog molecular weight
- 22124.12 g/mol
- Catalog sequence
- 191-amino-acid recombinant human growth hormone (somatropin)
- Identity boundary
- Recombinant protein identity requires intact mass, purity, folding/aggregation and potency controls; the catalog name alone is insufficient.
- Evidence status
- Established GH biology and regulated somatropin products; catalog material is not an approved drug
- Intended use
- Research, development and manufacturing use only
Literature reference parameters
- Compound or material class
- Recombinant human growth hormone research materialCatalog-family identity
- Evidence scope
- Established GH biology and regulated somatropin products; catalog material is not an approved drugDo not generalize beyond the cited model
- Source review
- Primary or authoritative records linked belowChecked 2026-09-01
Identity safeguard Reference identifiers above describe the literature compound record. Confirm the supplied form, formula, molecular weight, purity and storage conditions against the applicable product specification and any available lot records.
How HGH (GA) is studied
A target-to-pathway view grounded in the linked research records.
Reported research findings
What published studies report about HGH (GA)
Reported outcomes are paired with their experimental model and evidence boundary.
Human growth hormone was characterized as a distinct pituitary protein
Early biochemical literature established human growth hormone as a specific pituitary product.
Historical identity research does not verify recombinant manufacture or a current catalog lot.
Read the primary studyGH-axis interventions require indication-specific risk assessment
A review of GH secretagogues discusses efficacy and safety questions across the GH axis.
Class-level review evidence does not establish safe use of catalog HGH.
Read the primary studyCatalog options
Variant specifications
Pack-level catalog data; lot-level controls remain document-specific.
Specification & documents for H12
Product specification
Protein or hormone research material · 12 IU/vial nominal · 10-vial pack · identity and release tests controlled by lot specification.
Lot documentation
Document availability and scope must be confirmed for this variant and lot in the written quotation. A catalog description is not a lot-specific test result.
Specification & documents for H15
Product specification
Protein or hormone research material · 15 IU/vial nominal · 10-vial pack · identity and release tests controlled by lot specification.
Lot documentation
Document availability and scope must be confirmed for this variant and lot in the written quotation. A catalog description is not a lot-specific test result.
Specification & documents for H24
Product specification
Protein or hormone research material · 24 IU/vial nominal · 10-vial pack · identity and release tests controlled by lot specification.
Lot documentation
Document availability and scope must be confirmed for this variant and lot in the written quotation. A catalog description is not a lot-specific test result.
Specification & documents for H36
Product specification
Protein or hormone research material · 36 IU/vial nominal · 10-vial pack · identity and release tests controlled by lot specification.
Lot documentation
Document availability and scope must be confirmed for this variant and lot in the written quotation. A catalog description is not a lot-specific test result.
Specification & documents for H10
Product specification
Catalog unit is pending verification; do not treat the listed pack quantity as a released specification. Confirm the unit and formulation before quotation.
Lot documentation
Document availability and scope must be confirmed for this variant and lot in the written quotation. A catalog description is not a lot-specific test result.
Quality documentation
A listed document is not proof of availability for this lot. Ask the team to confirm the current COA status and the scope of any other records before ordering.
Analytical interpretation
Interpret the documents, not just the headline number.
Use the source-reviewed guide to separate chromatographic area purity, quantitative assay, LC-MS identity, composition and stability evidence before comparing variants or requesting a lot record.
Open the Quality & Documentation HubHPLC area ≠ assayA dominant peak does not establish target mass fraction.
Intact mass ≠ full sequenceIdentity strength depends on resolution and orthogonal evidence.
Counterions affect contentWater, salt form and solvents change the as-is composition.
Storage needs a data basisShipping practice is not the same as stability evidence.
Evidence map
Research context
Published studies and regulatory records, not customer testimonials or usage guidance.
Human growth hormone was characterized as a distinct pituitary protein
Historical identity research does not verify recombinant manufacture or a current catalog lot.
View primary recordGH-axis interventions require indication-specific risk assessment
Class-level review evidence does not establish safe use of catalog HGH.
View primary recordCurated references
Third-party publications selected for direct relevance.
-
01
Foundational human biology
Human growth hormone
Foundational review. 1968. PMID 4914846.
-
02
Safety review
The Safety and Efficacy of Growth Hormone Secretagogues
Sigalos JT, Pastuszak AW. 2018. PMID 28400207.
HGH (GA) questions
Concise answers for researchers comparing identity, evidence and catalog variants.
What effects are studied for HGH (GA)?
It is studied for tissue growth, protein metabolism, fat handling, and IGF-1 signaling. These are related biological processes, but a hormone response is not the same as stronger muscles or better physical function. Clinical benefits depend on the condition and approved medicine tested. This literature does not validate a catalog lot or support general bodybuilding or anti-aging claims.
How should the HGH (GA) research findings be understood?
An approved somatropin medicine is defined by its formulation, manufacturing, and approved uses, not just its protein sequence. A catalog lot does not inherit that identity. Confirming a recombinant growth hormone material needs lot-specific checks: intact mass, purity, proper folding, tendency to clump, and biological activity. Until then, drug trial findings describe the drug, not this material.
What evidence is available for HGH (GA)?
The biology and clinical development of human GH are extensive, while this page deliberately restricts conclusions to research identity and quality documentation.
Does the cited research validate this catalog material?
No. The cited records describe their own intervention, formulation, model and controls. They do not verify the identity, purity, sterility, safety or efficacy of a catalog lot.
Which quality documents can be requested?
A lot-specific COA, product specification sheet and analytical method summary can be requested where applicable.
How should HGH (GA) be stored?
Store at -20 °C, protected from light and moisture. After reconstitution, aliquot and avoid repeated freeze-thaw cycles. Confirm the applicable storage statement on the product-specific specification and lot documentation.
Knowledge tools
Continue with structured evidence
Move from this dossier into canonical evidence maps, verified status records, analytical interpretation and laboratory calculations.
Claims were checked against the linked primary publication, regulatory label or authoritative compound record. Published findings stay attached to their study model, formulation and route. Catalog identity and lot quality remain controlled by the applicable specification and lot-specific documents.
Technical procurement
Ready to request a quote?
Selected: H12 · 12 IU × 10 vials